Tracked deals
3
3 tracked deals across 2021-2022.
Arlington, Virginia, United States
Evolent partners with health plans and providers to improve outcomes for people with complex health conditions through clinical and administrative value-based care solutions, including specialty care management and total cost of care/care management.
Tracked deals
3
3 tracked deals across 2021-2022.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout
Last 2 years
Supporting Data
Evolent Health has entered into a definitive agreement to acquire NIA (also known as Magellan Specialty Health), the specialty benefit management business owned by Centene. The deal provides $650 million in upfront consideration plus up to $150 million of contingent consideration; Evolent expects revenue and EBITDA synergies and to fully integrate NIA into its value-based specialty care platform.
Evolent Health agreed to acquire IPG, a provider of surgical cost management solutions for musculoskeletal conditions, from TPG Growth for $375 million in cash plus up to $87 million of contingent consideration. The IPG platform will be integrated into Evolent’s New Century Health business to expand the company's value-based specialty care capabilities and add new payer and ambulatory surgery center relationships; the deal is expected to be immediately accretive to adjusted EBITDA.
Evolent Health acquired Vital Decisions, a New Jersey–based provider of technology-enabled advance care‑planning and telehealth services, from WindRose Health Investors. Vital Decisions will be folded into Evolent's specialty management offering, New Century Health, and consolidated into Evolent's Clinical Solutions segment to expand its specialty care and advance care‑planning capabilities.
Turn tracked acquisition activity into an outreach-ready buyer list.